Adoke Yeka
ID: UNCST-2021-R004300
|
An open-label, randomised, controlled, non-inferiority trial to compare the efficacy, safety and tolerability of a fixed dose Triple Artemisinin-based Combination Therapy (TACT) artemether-lumefantrine-amodiaquine versus first-line Artemisinin-based Combination Therapies (ACTs) for the treatment of uncomplicated Plasmodium falciparum malaria
REFNo: HS6344ES
To compare the efficacy of ALAQ vs AL and ALAQ vs ASAQ as defined by the 28-day PCR corrected adequate clinical and parasitological response (ACPR).
|
Uganda |
2025-09-26 17:41:17 |
2028-09-26 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Robert Ssekitoleko
ID: UNCST-2019-R001716
|
A Feasibility and Safety Study of the KeySuite Laparoscopic Devices for Cancer Diagnosis in Uganda
REFNo: SIR493ES
1. To evaluate potential safety issues associated with the use of the KeyScope in patients with intra-abdominal cancers or suspected cancers .
2. To determine the clinical performance of the KeyScope in viewing tissue masses in the abdomen.
3. To determine the clinical performance of the KeyLoop in retraction of the abdominal wall during laparoscopic surgery
4. To determine the acceptability of KeySuite laparoscopic devices in aiding to obtain laparoscopic biopsies
|
Uganda |
2025-09-26 17:12:49 |
2028-09-26 |
Engineering and Technology |
Clinical Trial |
Non-degree Award |
|
Martin Galiwango
ID: UNCST-2025-R017447
|
Image Classification in Dermatology: Real Time diagnosis of DCPA using edge computing
REFNo: SIR549ES
1. To identify the most optimal tier in the healthcare system where a DCPA diagnostic
device would improve the diagnosis of DCPA based on health workers’ diagnostic
accuracy and resource availability.
2. To train a deep learning model that can accurately diagnose DCPA.
3. To validate the deep learning model.
4. To implement the deep learning model on an edge-computing device that ensures data
privacy.
|
Uganda |
2025-09-26 16:31:26 |
2028-09-26 |
Engineering and Technology |
Non-Clinical Trial |
Degree Award |
|
Edgar Mulogo Mugema
ID: UNCST-2023-R008170
|
Focal mass drug administration for the prevention of malaria in pregnancy: a pilot randomized controlled trial.
REFNo: SS4303ES
1. Determine the feasibility and acceptability of a fMDA program with dihydroartemisinin-piperaquine (DP) as a novel component of the MiP prevention package. 2. Estimate the efficacy of fMDA to create a “safe zone” in the immediate home environment and ultimately prevent MiP. ,The scientific objective of this pilot study is to demonstrate the feasibility, acceptability, and preliminary effectiveness of a focal mass drug administration (fMDA) program for household members of pregnant women to protect against malaria in pregnancy (MiP).,
|
Uganda |
2025-09-26 16:24:58 |
2028-09-26 |
Social Science and Humanities |
|
Non-degree Award |
|
Abdullah Wailagala
ID: UNCST-2025-R019096
|
Anticipatory Action for Health Service Resilience and Detection (AHEAD) Discovery and Design Study
REFNo: HS6471ES
2) To understand the current and ideal approaches, practices, and perceptions of health workers regarding using risk data and/or information to trigger anticipatory actions.3) To collaboratively co-design, tools and frameworks for anticipatory epidemic risk monitoring and response, drawing on healthcare worker insights, existing workflows, and routine data systems at the primary health care level. 1) To assess the effectiveness and perceived impact of the cIDSR Ebola module released in response to the most recent Ebola outbreak in January 2025 in enhancing health facility readiness and response.
|
Uganda |
2025-09-24 16:38:20 |
2028-09-24 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|